Intelligence Platform
Patents
Browse 180 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11499166
Adeno-associated variants, formulations and methods for pulmonary delivery
granted patentUS 11497788
Supramolecular glycosaminoglycans
granted patentUS 11491231
Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the as
granted patentUS 11485976
Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same
granted patentUS 11458212
Molecular imaging of cancer cells in vivo
granted patentUS 11419949
Adeno-associated virus variant capsids and methods of use thereof
granted patentUS 11389544
Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly
granted patentUS 11364308
Adeno-associated virus variant capsids and methods of use thereof
granted patentUS 11364261
Alleviating common cold and influenza symptoms with molecular hydrogen
granted patentUS 11357860
Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mamm
granted patentUS 11357870
Codon optimized REP1 genes and uses thereof
granted patentUS 11345930
Codon optimized RPGRORF15 genes and uses thereof
granted patentUS 11220486
Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof
granted patentUS 11198858
Codon optimized GLA genes and uses thereof
granted patentUS 11179477
Method of using adeno-associated virus with variant capsid
granted patentUS 11167041
Adeno-associated virus variant capsids and methods of use thereof
granted patentUS 11147883
Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mamm
granted patentUS 11124835
Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular b
granted patentUS 11118192
Adeno-associated virus variant capsids and methods of use thereof
granted patentUS 11078471
Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)
granted patentUS 11066420
Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof
granted patentUS 11052157
Enhanced loading of intact, bacterially derived vesicles with small molecule compounds
granted patentUS 11041205
Molecular targets for ALS and related disorders
granted patentUS 10994014
Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
granted